4
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The role of natural products from medicinal plants against COVID-19: traditional medicine practice in Tanzania

      research-article
      Heliyon
      Elsevier
      COVID-19, Phytochemicals, Medicinal plants, Antiviral drugs, Phytochemical screening

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Pandemic COVID-19 is a dangerous disease caused by a new coronavirus known as severe acute respiratory syndrome (SARS-CoV-2). There is non-reliable drug or vaccine available to combat for SARS-CoV-2. More efforts to search for antiviral agents against COVID-19 are obligatory, whereas phytochemicals are potent solution. Thus, this study involved phytochemical screening and examining medicinal plants used to combat COVID-19 in Tanzania.

          Methods

          The plant materials were collected from practitioners. The plant extracts were then subjected for qualitative phytochemical screening so as to identify the nature of secondary metabolites.

          Results

          Eucalyptus species, pepper, berries, ginger, garlic, onions and lemon were identified as commonly plants used. The flavonoids, tannins, fatty acids, steroids, terpenoids, and saponins were identified through phytochemical screening. Identified natural phytocompounds revealed to be potential in exhibiting antiviral activities by disrupting the viral life cycle including viral entrance, replication, assembly, and discharge, as well as virus-specific host targets. Thus, this prompt increasing of pharmaceutical industry focused on phytochemical extracts from medicinal plants, and aromatic herbs in the hopes of discovering lead compounds, with purposeful to antiviral medications.

          Conclusion

          The medicinal plants and phytocompounds revealed to have significant role due to their substantial antiviral activity against SARS-CoV-2 and other coronaviruses. The noted natural products inspire collective efforts in determination and gathering funds to support scientific researchers to investigate more phytochemicals from medicinal plants for development of antiviral drug against COVID-19.

          Graphical abstract

          Abstract

          COVID-19; Phytochemicals; Medicinal plants; Antiviral drugs; Phytochemical screening.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

          An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses. A systematic comparison identified 380 amino acid substitutions between these coronaviruses, which may have caused functional and pathogenic divergence of 2019-nCoV.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Bioactive flavonoids in medicinal plants: Structure, activity and biological fate

            Graphical Abstract Unlabelled image
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)

              Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) represents an emergent global threat which is straining worldwide healthcare capacity. As of May 27th, the disease caused by SARS-CoV-2 (COVID-19) has resulted in more than 340,000 deaths worldwide, with 100,000 deaths in the US alone. It is imperative to study and develop pharmacological treatments suitable for the prevention and treatment of COVID-19. Ascorbic acid is a crucial vitamin necessary for the correct functioning of the immune system. It plays a role in stress response and has shown promising results when administered to the critically ill. Quercetin is a well-known flavonoid whose antiviral properties have been investigated in numerous studies. There is evidence that vitamin C and quercetin co-administration exerts a synergistic antiviral action due to overlapping antiviral and immunomodulatory properties and the capacity of ascorbate to recycle quercetin, increasing its efficacy. Safe, cheap interventions which have a sound biological rationale should be prioritized for experimental use in the current context of a global health pandemic. We present the current evidence for the use of vitamin C and quercetin both for prophylaxis in high-risk populations and for the treatment of COVID-19 patients as an adjunct to promising pharmacological agents such as Remdesivir or convalescent plasma.
                Bookmark

                Author and article information

                Contributors
                Journal
                Heliyon
                Heliyon
                Heliyon
                Elsevier
                2405-8440
                15 June 2022
                June 2022
                15 June 2022
                : 8
                : 6
                : e09739
                Affiliations
                [1]University of Dares Salaam, Mkwawa University College of Education, Department of Chemistry, P.O. Box 2513, Iringa, Tanzania
                Author notes
                []Corresponding author. stephanom7@ 123456gmail.com
                Article
                S2405-8440(22)01027-1 e09739
                10.1016/j.heliyon.2022.e09739
                9212986
                35747321
                794215f2-f95d-417b-a5ab-f88a935ee970
                © 2022 The Author(s)

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 24 February 2022
                : 22 April 2022
                : 13 June 2022
                Categories
                Research Article

                covid-19,phytochemicals,medicinal plants,antiviral drugs,phytochemical screening

                Comments

                Comment on this article